ReviewNature plants2025
The emerging epitranscriptomic modification ac
Review in Nature plants, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanopore direct RNA sequencing and the epitranscriptome: Advances in mapping native RNA landscapes.iMeta · 2026Review
- Emerging roles of non-mNature plants · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
N4-acetylcytidine is an evolutionarily conserved RNA modification that plays a key role in regulating transcript stability and translation. Although extensively studied in mammals, its prevalence and functional importance in plant transcriptomes remain unclear. Recent advances in transcriptome-wide mapping and functional characterization have revealed the important role of N4-acetylcytidine modification in plant-specific processes. Here we discuss how N4-acetylcytidine is deposited by plant writers, summarize its influence on plant development and adaptation, outline the major challenges and future directions in the field and highlight its potential applications for crop improvement.
Indexed as
Identifiers
41254201What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.